IMM 0.00% 34.0¢ immutep limited

brokers bullish on bioscience

  1. 2,977 Posts.
    lightbulb Created with Sketch. 481
    Today's snippet from a well-connected organisation dealing in Aussie biotechs.


    I believe we have all the hallmarks of a supercycle starting in Australia in life sciences. It is so similar to commodities, where years of underinvestment in R&D by big Pharma (in commodities it was exploration) has led to a genuine lack of new blockbuster drug supply, right as big Pharma faces the patent cliff. This is leading to big Pharma attempting to commercialise/accelerate development of next generation drugs/devices, many of which are patented by Australian listed companies. You will see more M&As and JVs in the Australian life sciences sector, which both reduces the requirement for equity capital from the sector and validates the science.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.000(0.00%)
Mkt cap ! $493.8M
Open High Low Value Volume
34.5¢ 35.0¢ 33.5¢ $724.1K 2.106M

Buyers (Bids)

No. Vol. Price($)
3 60483 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 55452 4
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.